About Allerim

Clinician-led guidance for immune-health questions that do not fit into one simple box.

Allerim connects guided navigation, specimen and testing logistics, laboratory context, clinical interpretation, and follow-through—without treating one symptom, marker, or theory as a diagnosis.

Clinician-led. Laboratory-informed. Evidence-traceable.

What Allerim connects

A connected path from the first question to the next supported decision.

People often arrive with an incomplete pattern: symptoms that vary, testing they do not understand, or several possible starting points. Allerim keeps those pieces connected while preserving uncertainty and clinical review.

01

Guided navigation

Food Wizard and Ask Allerim help organize the question and identify a reasonable route without diagnosing the person or automatically approving testing or treatment.

02

Testing logistics

When testing is an appropriate next step, Allerim connects the question to available at-home or local-draw options, specimen requirements, and secure continuation.

03

Laboratory context

A result reports what a method measured under defined conditions. Assay, specimen, measuring limits, and uncertainty stay connected to the clinical question.

04

Clinical interpretation and follow-through

Results are considered with symptoms, timing, exposures, history, and the decision the test was meant to inform. Clinical and operational actions keep their own review gates.

Clinical leadership at Allerim

Mark Pruitt, APRN, FNP

Mark's approach begins with a practical question: what would help make the next decision clearer? Sometimes that means organizing timing and exposures. Sometimes it means reviewing existing results. Sometimes testing may be useful, and sometimes a live clinical visit or a different route is the safer first step.

Clinical approach

Clarity before escalation.

Start with the real question

The biggest testing plan is not always the best first step. Begin with the question that would make the next decision clearer.

Interpret in context

Timing, exposures, symptoms, cofactors, prior results, and uncertainty matter. One number rarely tells the whole story.

Keep support proportional

Guided education, written review, secure follow-through, and live clinician time should each be used when they add value.

How Allerim approaches evidence

Clinical observation and laboratory measurement answer different parts of the question.

Allerim uses a disciplined dialogue between what is observed in real patients and what can be measured or investigated scientifically. The aim is to make evidence, uncertainty, and the next question visible.

What is observed clinically?
What can the assay actually measure?
What is biologically or mechanistically plausible?
What does published evidence support?
What remains theoretical or unvalidated?
What should not be concluded, and what should be checked next?
This process does not prove that one assay is superior, that one result caused a symptom, that at-home and venous specimens are equivalent, or that a theoretical pathway is clinically validated. A disagreement between results is a reason to review the exact tests and clinical story—not declare an automatic winner.

Clear roles

One connected system, with distinct responsibilities.

Allerim

The broad Precision Immune Health front door and guided routing layer.

AlphaGalTest

The focused alpha-gal testing and interpretation pathway.

Allerim Clinic

The clinician-practice, scheduling, and longitudinal-care surface.

Atlas

A separate educational, reasoning, and evidence-provenance workbench—not the clinical, laboratory, or workflow execution engine.

Allerim does not diagnose a condition from one number, promise a treatment result, or turn an analytical or theoretical signal into an automatic clinical decision.

Next step

Start with the question you are trying to answer.

Use Ask Allerim when the pattern is unclear. Explore testing and result-review routes when the question is more defined. Severe or rapidly worsening symptoms need urgent or emergency care rather than an online pathway.